|
2024
|
G/S
|
Pharmaceutical preparations; ophthalmic preparations; eye drops; pharmaceutical preparations for ... |
|
|
G/S
|
Eye drops; ophthalmological preparations; pharmaceutical products and preparations for ophthalmol... |
|
|
G/S
|
Eye drops; ophthalmological preparations; medical
preparations; oiled paper for medical purposes... |
|
|
Invention
|
Oral composition containing xanthophyll. The present disclosure provides a technology for maintai... |
|
|
Invention
|
Composition for improving retinal function. The present invention relates to: a composition for i... |
|
2023
|
Invention
|
Sterilized heterocyclidene-acetamide-derivative-containing suspension. The present disclosure pro... |
|
|
Invention
|
Combination preparation containing heterocyclidene acetamide derivative. The present disclosure p... |
|
|
Invention
|
Eye disease model animal. The present disclosure provides an eye disease model animal, a method f... |
|
|
Invention
|
Corneal endothelium ecm therapeutic medicaments.
The present invention provides medicaments for ... |
|
|
Invention
|
Agent for promoting corneal endothelial cell adhesion.
The invention provides an agent for promo... |
|
2022
|
Invention
|
Fluorescent probes.
A fluorescent probe that detects calpain enzyme activity with high sensitivi... |
|
|
Invention
|
Fluorescent probe. An object of the present invention is to provide a fluorescent probe that dete... |
|
|
Invention
|
Fluorescent probes. The purpose of the present invention is to provide a fluorescent probe that d... |
|
|
Invention
|
Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium.... |
|
|
Invention
|
Suspension containing heterocyclidene acetamide derivative.
The present disclosure provides susp... |
|
|
Invention
|
Suspension containing heterocyclidene acetamide derivative. Provided are suspension eye drops hav... |
|
2021
|
Invention
|
Nrf2-activating compound.
Compounds represented by formula (I), compounds of the less-polar grou... |
|
|
Invention
|
Nrf2-activating compound. The present invention addresses the problem of providing a compound hav... |
|
|
Invention
|
Therapeutic agent for covid-19.
The present invention aims to develop a method for treating COVI... |
|
|
Invention
|
Liquid preparation containing brimonidine. The purpose of the present invention is to provide a l... |
|
|
Invention
|
Bodily fluid collection device. A bodily fluid collection device includes a needle part having a ... |
|
|
Invention
|
Bodily fluid collecting device. Provided are a bodily fluid collecting device that is capable of ... |
|
|
Invention
|
Use of polyether compound.
The present disclosure provides the use of a polyether compound. In o... |
|
|
Invention
|
Use of polyether compound. The present disclosure provides the use of a polyether compound. In on... |
|
2020
|
Invention
|
Pharmaceutical composition. The purpose of the present invention is to provide a pharmaceutical c... |
|
|
Invention
|
Medicinal composition for soft contact lens. The purpose of the present invention is to provide a... |
|
|
Invention
|
Pharmaceutical composition for soft contact lens. The purpose of the present invention is to prov... |
|
|
Invention
|
Pharmaceutical drug containing heterocyclidene acetamide derivative. This disclosure provides a m... |
|
|
Invention
|
Nrf2-activating compound.
A compound having Nrf2-activating action is provided. The compound is ... |
|
|
Invention
|
Nrf2-activating compound. The invention addresses the problem of providing a compound having Nrf2... |
|
|
Invention
|
Novel use of nicotinamide mononucleotide (nmn) and nicotinamide riboside (nr).
The present discl... |
|
|
Invention
|
Novel use of nicotinamide mononucleotide (nmn) and nicotinamide riboside (nr). The present disclo... |
|
|
Invention
|
Composition for preventing or treating neurotrophic keratitis which contains pacap peptide or sta... |
|
|
Invention
|
Stabilized pacap peptide. The purpose of the present invention is to provide a PACAP peptide havi... |
|
|
Invention
|
Eye disease marker.
The present disclosure provides a marker that shows a relationship with chan... |
|
|
Invention
|
Eye disease marker. The present disclosure provides a marker that shows a relationship with chang... |
|
|
Invention
|
Pharmaceutical product. The purpose of the present invention is to provide technology relating to... |
|
|
Invention
|
Pharmaceutical product. A purpose of the present invention is to provide a technology pertaining ... |
|
|
Invention
|
Aqueous liquid formulation. The purpose of the present invention is to provide a formulation tech... |
|
|
Invention
|
Combined drug for treating or preventing retinal disease associated with angiogenesis. The purpos... |
|
|
Invention
|
Aqueous formulation. Provided is a stable aqueous formulation containing EPC-K. Also provided is ... |
|
|
Invention
|
Method for preparation of retinal ganglion cells. An object of the present invention is to provid... |
|
2019
|
Invention
|
Retinal ganglion cell death inhibitor.
The present invention relates to a retinal ganglion cell ... |
|
|
Invention
|
Retinal ganglion cell death inhibitor. The present invention pertains to: a retinal ganglion cell... |
|
|
Invention
|
Anionic drug-containing ophthalmic device. The objective of the present invention is to provide a... |
|
2018
|
Invention
|
Composition or method including (t)ew-7197 for treating or preventing corneal endothelial disease... |
|
|
Invention
|
Pacap stabilized peptide.
The purpose of the present invention is to provide a PACAP peptide hav... |
|
2017
|
G/S
|
Pharmaceutical preparations for ophthalmic use; eye drops; contact lens cleaning preparations; so... |
|
|
G/S
|
Chemicals; glue and adhesives for industrial purposes; plant
growth regulating preparations; che... |
|
|
Invention
|
Neuroprotective peptide. A peptide fragment isolated from proline-rich protein 4 (PRP4) has a neu... |
|
2015
|
G/S
|
Pharmaceutical preparations for use in ophthalmology; adhesive skin patches containing transderma... |
|
2012
|
G/S
|
Pharmaceutical preparations for ophthalmic use; eye drops;
contact lens cleaning preparations; s... |
|
2002
|
G/S
|
Chemical additives for use as ingredients in cosmetics Ingredients containing diester compound of... |
